Home
BDTX
BDTX News

Latest Black Diamond Therapeutics Inc. (BDTX) News on November 17, 2024

Associated Press Finance

12 days ago

Black Diamond: Q3 Earnings Snapshot

Vanda Pharmaceuticals Leads The Pack Of 3 US Penny Stocks

Simply Wall St.

12 days ago

Vanda Pharmaceuticals Leads The Pack Of 3 US Penny Stocks

Black Diamond Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

12 days ago

Black Diamond Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Black Diamond Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire

16 days ago

Black Diamond Therapeutics to Participate in Upcoming Investor Conferences

MT Newswires

a month ago

Black Diamond Cuts Programs, Workforce to Save Funding for Prospective Lung Cancer Therapy

Black Diamond Therapeutics Announces Restructuring Plan to Focus Resources on BDTX-1535 and Extend Cash Runway

GlobeNewswire

a month ago

Black Diamond Therapeutics Announces Restructuring Plan to Focus Resources on BDTX-1535 and Extend Cash Runway

Black Diamond Therapeutics' Lead Drug Candidate Shows Initial Anti-tumor Activity In Certain Type Of Lung Cancer Resistant To AstraZeneca's Drug

Benzinga

2 months ago

Black Diamond Therapeutics' Lead Drug Candidate Shows Initial Anti-tumor Activity In Certain Type Of Lung Cancer Resistant To AstraZeneca's Drug

MT Newswires

2 months ago

Sector Update: Health Care Stocks Rise Pre-Bell Monday

MT Newswires

2 months ago

Sector Update: Health Care

MT Newswires

2 months ago

Black Diamond Therapeutics Reports 'Robust Anti-Tumor Activity' in Phase 2 BDTX-1535 Trial for Cell Lung Cancer

MT Newswires

2 months ago

Top Premarket Gainers

Black Diamond Therapeutics Announces Initial Phase 2 Data Demonstrating Robust Anti-tumor Activity of BDTX-1535 in Patients with Recurrent EGFRm NSCLC who Present with a Broad Spectrum of Classical, Non-classical, and C797S Resistance Mutations

GlobeNewswire

2 months ago

Black Diamond Therapeutics Announces Initial Phase 2 Data Demonstrating Robust Anti-tumor Activity of BDTX-1535 in Patients with Recurrent EGFRm NSCLC who Present with a Broad Spectrum of Classical, Non-classical, and C797S Resistance Mutations

Black Diamond Therapeutics to Host Webcast Presentation of Initial Phase 2 BDTX-1535 Data in Patients With Recurrent EGFRm NSCLC

GlobeNewswire

2 months ago

Black Diamond Therapeutics to Host Webcast Presentation of Initial Phase 2 BDTX-1535 Data in Patients With Recurrent EGFRm NSCLC

Black Diamond Therapeutics Presents Real-World Treatment Practices and Patient Outcomes in Newly Diagnosed NSCLC Patients with Non-Classical Mutations at the European Society for Medical Oncology (ESMO) Congress 2024

GlobeNewswire

2 months ago

Black Diamond Therapeutics Presents Real-World Treatment Practices and Patient Outcomes in Newly Diagnosed NSCLC Patients with Non-Classical Mutations at the European Society for Medical Oncology (ESMO) Congress 2024

Gyre Therapeutics Announces Appointment of David M. Epstein, Ph.D., to Board of Directors

GlobeNewswire

3 months ago

Gyre Therapeutics Announces Appointment of David M. Epstein, Ph.D., to Board of Directors

All You Need to Know About Black Diamond (BDTX) Rating Upgrade to Buy

Zacks

3 months ago

All You Need to Know About Black Diamond (BDTX) Rating Upgrade to Buy

Associated Press Finance

3 months ago

Black Diamond: Q2 Earnings Snapshot

Black Diamond Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

3 months ago

Black Diamond Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update

MT Newswires

4 months ago

Raymond James Initiates Black Diamond Therapeutics at Outperform

Will Black Diamond Therapeutics (NASDAQ:BDTX) Spend Its Cash Wisely?

Simply Wall St.

5 months ago

Will Black Diamond Therapeutics (NASDAQ:BDTX) Spend Its Cash Wisely?

Is Black Diamond Therapeutics, Inc. (BDTX) a Good Biotech Penny Stock to Buy Right Now?

Insider Monkey

5 months ago

Is Black Diamond Therapeutics, Inc. (BDTX) a Good Biotech Penny Stock to Buy Right Now?

Black Diamond Therapeutics Presents Promising BDTX-1535 Clinical Data in Patients with Recurrent Glioblastoma at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

GlobeNewswire

6 months ago

Black Diamond Therapeutics Presents Promising BDTX-1535 Clinical Data in Patients with Recurrent Glioblastoma at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference

GlobeNewswire

6 months ago

Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) is favoured by institutional owners who hold 60% of the company

Simply Wall St.

6 months ago

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) is favoured by institutional owners who hold 60% of the company

MT Newswires

6 months ago

HC Wainwright Adjusts Price Target on Black Diamond Therapeutics to $11 From $12, Keeps Buy Rating

Should You Buy Black Diamond Therapeutics (BDTX) Ahead of Earnings?

Zacks

6 months ago

Should You Buy Black Diamond Therapeutics (BDTX) Ahead of Earnings?

Black Diamond Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

6 months ago

Black Diamond Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

Associated Press Finance

6 months ago

Black Diamond: Q1 Earnings Snapshot

Black Diamond Therapeutics Announces Presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

GlobeNewswire

7 months ago

Black Diamond Therapeutics Announces Presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Black Diamond (BDTX) Upgraded to Buy: What Does It Mean for the Stock?

Zacks

7 months ago

Black Diamond (BDTX) Upgraded to Buy: What Does It Mean for the Stock?

Black Diamond Therapeutics Announces Changes to Board of Directors

GlobeNewswire

7 months ago

Black Diamond Therapeutics Announces Changes to Board of Directors

Wall Street Analysts Predict a 129.25% Upside in Black Diamond (BDTX): Here's What You Should Know

Zacks

7 months ago

Wall Street Analysts Predict a 129.25% Upside in Black Diamond (BDTX): Here's What You Should Know

Black Diamond Therapeutics Presents Novel Real-World Evidence of the Evolving EGFR Mutation Landscape in NSCLC and the Opportunity for BDTX-1535 in an Oral Presentation at the 2024 American Association of Cancer Research Annual Meeting

GlobeNewswire

7 months ago

Black Diamond Therapeutics Presents Novel Real-World Evidence of the Evolving EGFR Mutation Landscape in NSCLC and the Opportunity for BDTX-1535 in an Oral Presentation at the 2024 American Association of Cancer Research Annual Meeting

Black Diamond Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire

7 months ago

Black Diamond Therapeutics to Participate in Upcoming Investor Conferences

How Much Upside is Left in Black Diamond Therapeutics (BDTX)? Wall Street Analysts Think 95.93%

Zacks

8 months ago

How Much Upside is Left in Black Diamond Therapeutics (BDTX)? Wall Street Analysts Think 95.93%

GuruFocus.com

8 months ago

Black Diamond Therapeutics Inc (BDTX) Reports Q4 and Full Year 2023 Financials, Advances ...

Associated Press Finance

8 months ago

Black Diamond: Q4 Earnings Snapshot

Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

GlobeNewswire

8 months ago

Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Black Diamond Therapeutics Announces Upcoming Presentation at AACR Annual Meeting 2024

GlobeNewswire

8 months ago

Black Diamond Therapeutics Announces Upcoming Presentation at AACR Annual Meeting 2024

Black Diamond Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference

GlobeNewswire

9 months ago

Black Diamond Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference

FANHUA Announces Significant Investment from White Group

GlobeNewswire

9 months ago

FANHUA Announces Significant Investment from White Group

LifeMD (NASDAQ:LFMD) shareholders have earned a 49% CAGR over the last five years

Simply Wall St.

10 months ago

LifeMD (NASDAQ:LFMD) shareholders have earned a 49% CAGR over the last five years

18 Best 52-Week Low Stocks To Buy Now

Insider Monkey

10 months ago

18 Best 52-Week Low Stocks To Buy Now

GlobeNewswire

10 months ago

RGC Resources, Inc. Schedules First Quarter 2024 Earnings Call

BlackRock Capital Investment Corporation to Report Fourth Quarter 2023 Earnings on March 5, 2024

Business Wire

10 months ago

BlackRock Capital Investment Corporation to Report Fourth Quarter 2023 Earnings on March 5, 2024

USCB Financial Holdings Inc Reports Mixed Results Amid Economic Headwinds

GuruFocus.com

10 months ago

USCB Financial Holdings Inc Reports Mixed Results Amid Economic Headwinds

Heron Therapeutics' Non-Opioid, Post-Operative Pain Drug Approved For Use In Additional Orthopedic, Soft Tissue Procedures - FDA Gives Nod

Benzinga

10 months ago

Heron Therapeutics' Non-Opioid, Post-Operative Pain Drug Approved For Use In Additional Orthopedic, Soft Tissue Procedures - FDA Gives Nod

Aragon Research positions LivePerson as a Leader in The Aragon Research Globe™ Report for Conversational AI, 2024

PR Newswire

10 months ago

Aragon Research positions LivePerson as a Leader in The Aragon Research Globe™ Report for Conversational AI, 2024

LivePerson (LPSN) Opts for Net Operating Loss Rights Plan

Zacks

10 months ago

LivePerson (LPSN) Opts for Net Operating Loss Rights Plan

SpartanNash Implements New Food Traceability Program, Strengthening Safety and Transparency Throughout Its Global Supply Chain

PR Newswire

10 months ago

SpartanNash Implements New Food Traceability Program, Strengthening Safety and Transparency Throughout Its Global Supply Chain

Software Development Stocks Q3 Earnings: Datadog (NASDAQ:DDOG) Best of the Bunch

StockStory

10 months ago

Software Development Stocks Q3 Earnings: Datadog (NASDAQ:DDOG) Best of the Bunch

Expanding ReposiTrak Traceability Network Welcomes Nut Butter Supplier and Three New Produce Suppliers

Business Wire

10 months ago

Expanding ReposiTrak Traceability Network Welcomes Nut Butter Supplier and Three New Produce Suppliers

Sify Technologies Limited (NASDAQ:SIFY) Q3 2024 Earnings Call Transcript

Insider Monkey

10 months ago

Sify Technologies Limited (NASDAQ:SIFY) Q3 2024 Earnings Call Transcript

Is Black Diamond Therapeutics (NASDAQ:BDTX) In A Good Position To Invest In Growth?

Simply Wall St.

10 months ago

Is Black Diamond Therapeutics (NASDAQ:BDTX) In A Good Position To Invest In Growth?

Invesco Municipal Trust's Dividend Analysis

GuruFocus.com

10 months ago

Invesco Municipal Trust's Dividend Analysis

AVITA Medical Announces Exclusive Distribution Agreement with Stedical Scientific

GlobeNewswire

10 months ago

AVITA Medical Announces Exclusive Distribution Agreement with Stedical Scientific

AVITA Medical Announces Preliminary 2023 Financial Highlights, Provides 2024 Financial Guidance and Business Update

GlobeNewswire

10 months ago

AVITA Medical Announces Preliminary 2023 Financial Highlights, Provides 2024 Financial Guidance and Business Update

Baillie Gifford Trims Position in Codexis Inc

GuruFocus.com

10 months ago

Baillie Gifford Trims Position in Codexis Inc

Owning 48% shares,institutional owners seem interested in Aura Biosciences, Inc. (NASDAQ:AURA),

Simply Wall St.

10 months ago

Owning 48% shares,institutional owners seem interested in Aura Biosciences, Inc. (NASDAQ:AURA),

Black Diamond Therapeutics Announces Corporate Update and Expected 2024 Milestones

GlobeNewswire

10 months ago

Black Diamond Therapeutics Announces Corporate Update and Expected 2024 Milestones

Wall Street Analysts See a 197.7% Upside in C4 Therapeutics, Inc. (CCCC): Can the Stock Really Move This High?

Zacks

a year ago

Wall Street Analysts See a 197.7% Upside in C4 Therapeutics, Inc. (CCCC): Can the Stock Really Move This High?

LianBio Announces Departure of Chief Financial Officer

GlobeNewswire

a year ago

LianBio Announces Departure of Chief Financial Officer

FVCBankcorp (FVCB) Soars 5.9%: Is Further Upside Left in the Stock?

Zacks

a year ago

FVCBankcorp (FVCB) Soars 5.9%: Is Further Upside Left in the Stock?

Molecular Partners to Present at 42nd Annual J.P. Morgan Healthcare Conference and Swiss Investor Conferences

GlobeNewswire

a year ago

Molecular Partners to Present at 42nd Annual J.P. Morgan Healthcare Conference and Swiss Investor Conferences

Judith A. Reinsdorf and Katherine M. Sandstrom Named to Toll Brothers Board of Directors

GlobeNewswire

a year ago

Judith A. Reinsdorf and Katherine M. Sandstrom Named to Toll Brothers Board of Directors

Augmedix Partners with Google Cloud to Bring Medically-Tuned AI Technology to Ambient Documentation

PR Newswire

a year ago

Augmedix Partners with Google Cloud to Bring Medically-Tuned AI Technology to Ambient Documentation

Whitestone REIT Board of Trustees Responds to Proposal from Bruce Schanzer / Erez Asset Management, LLC (“Erez”)

GlobeNewswire

a year ago

Whitestone REIT Board of Trustees Responds to Proposal from Bruce Schanzer / Erez Asset Management, LLC (“Erez”)

Black Diamond Therapeutics Announces Topline Results from Phase 1 Dose Escalation Trial of BDTX-1535 in Patients with Recurrent GBM

GlobeNewswire

a year ago

Black Diamond Therapeutics Announces Topline Results from Phase 1 Dose Escalation Trial of BDTX-1535 in Patients with Recurrent GBM

New Strong Buy Stocks for December 8th

Zacks

a year ago

New Strong Buy Stocks for December 8th

3 Stocks at the Forefront of Personalized Medicine Trend

InvestorPlace

a year ago

3 Stocks at the Forefront of Personalized Medicine Trend

With 58% ownership, Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) boasts of strong institutional backing

Simply Wall St.

a year ago

With 58% ownership, Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) boasts of strong institutional backing

Investing in Hallador Energy (NASDAQ:HNRG) three years ago would have delivered you a 964% gain

Simply Wall St.

a year ago

Investing in Hallador Energy (NASDAQ:HNRG) three years ago would have delivered you a 964% gain

Duluth Holdings Inc. (NASDAQ:DLTH) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

Duluth Holdings Inc. (NASDAQ:DLTH) Q3 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

a year ago

Q3 2023 Duluth Holdings Inc Earnings Call

Duluth (DLTH) Q3 2023 Earnings Call Transcript

Motley Fool

a year ago

Duluth (DLTH) Q3 2023 Earnings Call Transcript

Business Wire

a year ago

Everest Consolidator Acquisition Corporation Receives NYSE Notice Regarding Delayed Form 10-Q Filing

Richtech Robotics Announces Closing of Upsized Initial Public Offering

GlobeNewswire

a year ago

Richtech Robotics Announces Closing of Upsized Initial Public Offering

Why BeautyHealth (SKIN) Shares Are Sliding Today

StockStory

a year ago

Why BeautyHealth (SKIN) Shares Are Sliding Today

Biodesix Enhances Access to Nodify Lung® Testing with Launch of New Blood Draw Method

Business Wire

a year ago

Biodesix Enhances Access to Nodify Lung® Testing with Launch of New Blood Draw Method

GuruFocus.com

a year ago

The Beauty Health Co (SKIN) Faces Headwinds: Q3 Earnings Reveal Challenges and Revised Guidance

BeautyHealth Reports Third Quarter 2023 Financial Results

Business Wire

a year ago

BeautyHealth Reports Third Quarter 2023 Financial Results

Insider Stock Buying Reaches US$665.9k On Pennant Group

Simply Wall St.

a year ago

Insider Stock Buying Reaches US$665.9k On Pennant Group

Biodesix to Participate in Two Upcoming Investor Conferences in November

Business Wire

a year ago

Biodesix to Participate in Two Upcoming Investor Conferences in November

Black Diamond Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire

a year ago

Black Diamond Therapeutics to Participate in Upcoming Investor Conferences

Associated Press Finance

a year ago

JELD-WEN: Q3 Earnings Snapshot

JELD-WEN Holding Inc (JELD) Reports Q3 2023 Results, Raises Full-Year Guidance

GuruFocus.com

a year ago

JELD-WEN Holding Inc (JELD) Reports Q3 2023 Results, Raises Full-Year Guidance

You Can Buy All 4 of These Ultra-High Yield Dividend Stocks for Less Than $100

Motley Fool

a year ago

You Can Buy All 4 of These Ultra-High Yield Dividend Stocks for Less Than $100

Share on Social Networks: